Prelude Capital Management’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-25,817
| Closed | -$87.3K | – | 1335 |
|
|
2025
Q1 | $87.3K | Buy |
25,817
+8,017
| +45% | +$27.1K | 0.01% | 968 |
|
|
2024
Q4 | $101K | Sell |
17,800
-2,800
| -14% | -$15.9K | 0.01% | 964 |
|
|
2024
Q3 | $121K | Buy |
+20,600
| New | +$121K | 0.01% | 1036 |
|
|
2023
Q4 | – | Sell |
-11,715
| Closed | -$90.8K | – | 1257 |
|
|
2023
Q3 | $90.8K | Buy |
+11,715
| New | +$90.8K | 0.01% | 860 |
|
|
2020
Q1 | – | Sell |
-147
| Closed | -$2K | – | 1608 |
|
|
2019
Q4 | $2K | Buy |
147
+39
| +36% | +$531 | ﹤0.01% | 1344 |
|
|
2019
Q3 | $2K | Sell |
108
-11
| -9% | -$204 | ﹤0.01% | 1116 |
|
|
2019
Q2 | $3K | Buy |
119
+44
| +59% | +$1.11K | ﹤0.01% | 1154 |
|
|
2019
Q1 | $1K | Sell |
75
-82
| -52% | -$1.09K | ﹤0.01% | 1306 |
|
|
2018
Q4 | $1K | Buy |
157
+116
| +283% | +$739 | ﹤0.01% | 1345 |
|
|
2018
Q3 | $1K | Buy |
+41
| New | +$1K | ﹤0.01% | 1320 |
|
|
2018
Q2 | – | Sell |
-500
| Closed | -$9K | – | 1685 |
|
|
2018
Q1 | $9K | Buy |
+500
| New | +$9K | ﹤0.01% | 1212 |
|
|
2016
Q3 | – | Sell |
-2,143
| Closed | -$24K | – | 1766 |
|
|
2016
Q2 | $24K | Buy |
+2,143
| New | +$24K | ﹤0.01% | 1170 |
|